Skip to main content

Additional evidence for the role of chromosomal imbalances and SOX8, ZNRF3 and HHAT gene variants in early human testis development



Forty-six ,XY Differences/Disorders of Sex Development (DSD) are characterized by a broad phenotypic spectrum ranging from typical female to male with undervirilized external genitalia, or more rarely testicular regression with a typical male phenotype. Despite progress in the genetic diagnosis of DSD, most 46,XY DSD cases remain idiopathic.


To determine the genetic causes of 46,XY DSD, we studied 165 patients of Tunisian ancestry, who presented a wide range of DSD phenotypes. Karyotyping, candidate gene sequencing, and whole-exome sequencing (WES) were performed.


Cytogenetic abnormalities, including a high frequency of sex chromosomal anomalies (85.4%), explained the phenotype in 30.9% (51/165) of the cohort. Sanger sequencing of candidate genes identified a novel pathogenic variant in the SRY gene in a patient with 46,XY gonadal dysgenesis. An exome screen of a sub-group of 44 patients with 46,XY DSD revealed pathogenic or likely pathogenic variants in 38.6% (17/44) of patients.


Rare or novel pathogenic variants were identified in the AR, SRD5A2, ZNRF3, SOX8, SOX9 and HHAT genes. Overall our data indicate a genetic diagnosis rate of 41.2% (68/165) in the group of 46,XY DSD.


Differences/Disorders of Sex Development (DSDs) are defined as congenital conditions with a discrepancy between chromosomal, gonadal, and phenotypic sex [1]. They represent a major clinical concern that is most often present in newborns or adolescents [2]. The prevalence of DSD is often underestimated since the diagnosis can be relatively late, at puberty or during adulthood and, in some countries, sexual issues are still sensitive, resulting in a reluctance to seek clinical counselling [3]. This may explain why in Saudi Arabia and Egypt, the incidence of ambiguous genitalia is estimated to be 1:2,500 and 1: 3,000 of live births, respectively, whilst in European countries it is estimated at 1: 4,500–1: 5,500 of live births [4,5,6,7].The data could also reflect the high rate of consanguinity, especially in developing countries, where autosomal recessive forms of DSD are more prevalent [8]. Population isolates may also contribute to the presence of rare or novel variants with a limited geographic range [8].

Forty-six ,XY DSD can be due to chromosome abnormalities or genetic variants in the genes involved in the development or function of the male gonad as well as anomalies of downstream target tissues [9]. In most studies, the genetic cause is established in less than 50% of 46,XY DSD cases [1, 9, 10]. At a molecular level pathogenic variants in the AR, NR5A1, SRD5A2, ZFPM2, HSD17B3 and DHH genes are the most frequent causes of 46,XY DSD [9, 10]. The aim of this study was to define the genetic etiology in a large cohort of 46,XY DSD patients from a North African population and compare these data to those observed in other populations. The cytogenetic analysis and molecular gene approaches resulted in a combined diagnosis yield of 41.2% (68/165) for this DSD subgroup. Cytogenetic analysis detected autosomal or sex chromosome anomalies in 30.9% of all cases, whereas WES identified rare or novel variants in the AR, SRD5A2, ZNRF3, SOX8, SOX9 and HHAT genes (17/44 cases; 38.6%). These results emphasize the usefulness of both cytogenetic approaches as well as exome sequencing to make an accurate genetic diagnosis for a better genetic counseling and knowledge-based management of this group of patients.

Patients and methods

Cohort and study design

A total of 165 patients with DSD were referred for genetic consultation in the department of Cytogenetic, Molecular biology, and Biology of Human Reproduction, Teaching hospital Farhat Hached, Sousse, Tunisia over a period of 3 years (2018–2020). The local Ethics Board of the University Teaching Hospital Farhat Hached approved the present study (IRB00008931) and written consents were taken from adult probands or from the parents when the patient was under 18 years. The patients presented with a range of clinical DSD profiles and their ages ranged from birth to 35 years. They underwent a complete clinical examinations, including genital examination, family history and examination for the presence of somatic abnormalities. Imaging examination and hormonal evaluation were also carried out according to each case. Patients with suspected or confirmed congenital adrenal hyperplasia (CAH) were excluded from this study. All patients are from Tunisian ancestry.

Genetic analysis

Cytogenetic studies

Reverse Heat Giemsa (RHG) banded karyotype was performed on metaphase chromosome preparations obtained from peripheral blood lymphocytes of both patients and parents according to standard protocol (450–550 band level). A minimum of 20 R-banded metaphase chromosomes were analyzed using Cytovision® Karyotyping software version 4.0. Karyotypes were classified according to the International System of Human Cytogenetic Nomenclature (ISCN 2020) [11]. Fluorescent in situ Hybridization (FISH) was carried out on metaphase chromosomes of the patients according to the standard protocol, using commercial probes. Array Comparative genomic hybridization (aCGH) 4 × 44 K micro-arrays was performed using the Agilent platform according to the manufacturer’s instructions (Feature Extraction 9.1, CGH Analytics 4.5, Santa Clara, California, United States). An abnormal ratio greater than + 0.58 or lower than − 0.75 was considered as an alteration. An in silico analysis of the unbalanced regions was executed using UCSC Genome Browser (, the Database of Chromosome Imbalance and Phenotype in Humans using Ensemble Resources (DECIPHER:, the Database of Genomic Variants (DGV: and the Online Mendelian Inheritance in Man database (OMIM:

Sanger sequencing

Genomic DNA was extracted from the peripheral blood of the patient using the FlexiGene DNA Kit (Qiagen, Hilden, Germany). Direct Sanger sequencing was performed using the Big Dye Terminator V3.1 Cycle Sequencing, on the ABI 3730XL sequencer (Applied Biosystems, Foster City, CA, USA). Sequencing data were analyzed by SeqScape 2.0 software (Applied Biosystems).

Whole exome sequencing

The WES approach was performed on DNA from 44 XY individuals who had a complete clinical investigation including examination of genitalia, hormonal screens and, where possible, gonad histology. All of these patients presented with a broad spectrum of 46,XY DSD phenotypes for which the underlying cause is unknown.

Exonic and adjacent intronic sequences were enriched from genomic DNA using Agilent SureSelect Human All Exon V4, and paired-end sequencing was done with the TruSeq v3 chemistry on Illumina HiSeq2000 platform. Based on the manufacturer's proprietary software, reads were mapped using the Burrows-Wheeler Aligner. Single nucleotide variants (SNV) and small insertions or deletions (Indels) were generated with GATK 1.6 version. BAM files were also carried out using SAMtools version 0.1.18. GATK. Unified Genotyper software was used for calling single nucleotide polymorphism (SNP) and Indels variants for each patient.

The annotated VCF files were then formatted to be used as a Microsoft Excel spreadsheet software and a selection of variants according to well-defined criteria (degree of pathogenicity, type of variant, frequency of the variant in all populations, including sub population) was performed. Synonymous, intronic and non-coding RNA variants were removed. Missense, nonsense, insertion/deletion and splice-site variants that were homozygous with a Minor Allele Frequency (MAF) of > 0.01 were excluded and heterozygous variants with a MAF of > 0.001 according to the GnomAD database ( were also excluded.

According to the clinical data of each patient, the analysis of variants was performed through a range of web-based bioinformatics tools. The variant Effect Predictor(VEP) bioinformatics tool on the Ensembl website (, gnomAD(,ClinVar ( and Database of Genomic Variants ( were used to annotated the novel variants.

The possible impact on protein structure and function was evaluated to determine the pathogenicity of the variants based on individual scores made by Sorting Intolerant from Tolerant (SIFT),Polymorphism phenotyping V2( PolyPhen2) and Rare Exome Variant Ensemble Learner (REVEL; [12]) tools.

The Clustal Omega tool ( was used to generate alignments between three or more protein sequences. The Hope tool was used to analyze the structural effects of a point variation in a protein sequence [13].

Clinical significance was established according to the 2015 American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG) in order to establish a better genotype–phenotype correlation. [14]. Potentially pathogenic variants were verified by Sanger sequencing.

The WES cohort of 46,XY DSD consisted of 19 individuals raised as females and 25 raised as males. Within this group, 17 cases were syndromic and 27 cases non-syndromic cases.


The most common feature at consultation was atypical external genitalia (67 patients) or typical male external genitalia with azoospermia (42 patients). A total of 30 patients presented with other congenital anomalies including intellectual deficiency, dysmorphic features, heart defects growth delay and cerebral anomalies. Primary amenorrhea and delayed puberty were reported in 18 and 8 cases respectively (Table 1). In this cohort, the patients were classified into three groups: Sex chromosome DSD, autosomal chromosomal abnormalities and 46,XY DSD (Table 1). 66% of the studied patients (110/165) were diagnosed as having 46,XY DSD of whom 23% were raised as females.

Table 1 Presentation of different categories of studied DSD Tunisian cohort

Cytogenetic results

The proportions of different categories of DSD are shown in Table 1 and the distribution of patients with sex chromosome DSD in relation to their karyotype is illustrated in Fig. 1.

Fig. 1
figure 1

Distribution of patients with sex chromosome DSD according to their karyotype. 47,XXY was the most common observation

Sex chromosome anomalies were detected in 48/165 patients (29.1%) and autosomal chromosome abnormalities were detected in three individuals (1.8%). Klinefelter syndrome (KS) was the most prevalent chromosome sex abnormality in (87.2%) and genetic cause of azoospermia (83.3%) in males.

aCGH was performed on twenty patients based on their clinical presentation, suggesting a contiguous gene syndrome or an a priori assumption of the involvement of rearrangements affecting known gonadal genes or their regulatory sequences with various other extragonadal malformations. In 8 patients, anomalies were observed (Table 2).

Table 2 Clinical and cytogenetic findings in patients with DSD explored with aCGH (4 × 44 K)

These included five cases with intra-chromosomal deletions, two cases of intra-chromosomal duplications, and one case with an inversion duplication/deletion (invdupdel) chromosome imbalance (Table 2). Of these chromosomal anomalies, genes known to cause 46,XY DSD were identified for 4 patients (Table 2) including DMRT1, GATA4 and NR0B1. FISH analysis confirmed the heterozygous deletion of the GATA4 gene in patient 2 and a duplication of the NR0B1 gene in patient 3. The patient 1 presented the Wolf–Hirschhorn syndrome (WHS) [OMIM#194190]. In addition to the typical WHS phenotype, he presented a hypospadias, micropenis and cryptorchidism. The 4p16.3 deletion presumably results in haploinsufficiency of the MSX1 gene [OMIM#142983] whose absence might be indirectly responsible for the hypospadias phenotype as this gene contributes to the spatiotemporal regulation of GnRH transcription during development [15]. In three patients (patients 6–8), there was no obvious candidate gene located within the chromosomal anomaly. Clinical details and cytogenetic results are summarized in Table 2.

Sequencing data

Exome sequencing was performed in a total of 44 patients with 46,XY DSD. Amongst them, 27 were non-syndromic and 17 presented with somatic anomalies. Of the 44 patients, a genetic cause was established in 17 cases (38.6%) of whom 13 presented non-syndromic DSD form and 4 with syndromic forms. Likely benign (LB) and variants of uncertain significance (VUS) were identified in 11/27 non-syndromic individuals (40.7%) and 4/17 (23.5%) of syndromic individuals. Pathogenic and likely pathogenic variants in the following genes: AR (n = 6), SRD5A2 (n = 2), LHCGR (n = 1), ZNRF3 (n = 1), HHAT (n = 1), SOX8 (n = 1), IER3IP 1(n = 1), SRY (n = 1), SOX9 (n = 1), FLNA (n = 1) and PEX1 (n = 1). The Clinical and molecular findings are summarized in Table 3.

Table 3 Clinical phenotype, hormonal profil and details of potentially pathogenic variants identified by WES in a cohort of individuals with 46,XY DSD

The most common genetic diagnosis was variants in the androgen receptor (26%, 7/27).

A de novo pathogenic variant (p.S426*) in the AR gene was observed in two sisters who presented complete androgen insensitivity syndrome (CAIS). Two other affected girls with CAIS from unrelated families (DSD3 and DSD4) shared a pathogenic variant (p.G744E), suggesting a possible founder effect. We identified novel or rare likely pathogenic variants in the ZNRF3 (DSD 11), HHAT (DSD 12), and SOX8 genes (DSD 30). A girl with 46,XY complete gonadal dysgenesis carried novel missense heterozygous ZNRF3 variant (p.I338M). According to SIFT (0.01), PP2 (0.519) and REVEL (0.461) scores, this variant is likely to be disease causing. Isoleucine 338 is a highly conserved residue within the long intracellular domain (Fig. 2A), immediately adjacent to the ring domain (amino acids 293–334), which is responsible for the E3 ubiquitin ligase activity. A newborn 46,XY girl (DSD 12) presented hydrocephalus, skeletal malformations, bilateral anophtalmos and agenesis of the corpus callosum carried a very rare homozygous variant (p.R312S) in HHAT gene (DSD 12). The evolutionary conserved p.R312 residue is located in the Membrane Bound O-Acyltransferase domain 2 (MBOAT 2; Fig. 2B), which is required to palmitoylate Hedgehog proteins including SHH and DHH [16]. The in silico tools PP2 (0.99), SIFT (0.04) and REVEL (0.812) showed that this variant is likely to be disease causing. Hope tool predicted this variant to be damaging for the protein since the mutation introduces a more hydrophobic residue at this position and this can result in loss of hydrogen bonds and/or disturb correct folding. A novel heterozygotic p.T226P variant in SOX8 gene was identified in a 46,XY female with probable testicular regression syndrome (high FSH, LH levels, no residual gonad, absent vagina and uterus). The T226 residue, located within the transactivation domain 1, is highly conserved among vertebrates and within the SOXE group of proteins (Fig. 2C). PP2 prediction tool indicated that this variant is likely disease causing. Hope predicted this variant to be likely damaging to the protein since it is located in an important domain for the main activity of the protein. The charge of the wild-type residue will be lost, and that change can cause loss of interactions with other molecules or residues. The inheritance pattern of both the ZNRF3 and SOX8 variants is unknown as parents DNA was unavailable. Both variants are absent from all public databases.

Fig. 2
figure 2

A Schematic representation of ZNRF3 protein indicating the known functional domains. The sequence alignment indicating the position and evolutionary conservation of the mutated isoleucine 338 residue, immediately adjacent to the RING finger domain. Previously published variants linked to 46,XY DSD are shown and located within the intracellular domain. B Schematic representation of HHAT protein indicating the position of the mutated p.R312 residue. Other published variants associated with this syndromic form of 46,XY DSD are indicated. C Representation of the SOX8 protein showing the position of the mutated p.T226 residue located in the evolutionary conserved TA1 domain. The only other SOX8 variant known to be associated with 46,XY DSD is the p.E156D mutation located within the HMG-box. Right, the mutated threonine residue is conserved in the SOXE group of proteins. DIM, DNA-dependent dimerization domain; HMG, high mobility group; MBOAT, Membrane Bound O-Acyltransferase domain; TA, transactivation domain; TM, transmembrane domain; SP, signal peptide

A rare homozygous variant in PEX1 gene (p.G843D) was identified in a child boy (DSD 17) with syndromic form of DSD, including microcephaly, partial agenesis of the corpus callosum, dysmorphic features and unilateral cryptorchidism. SIFT (0), PP2 (1) and REVEL (0.984) prediction tools indicated that this variant is likely disease causing.


Sex chromosome as well as autosomal anomalies were present in 30.9% of the 46,XY DSD cohort, with the majority classified as 47,XXY Klinefelter’s syndrome. This is similar to frequencies reported by Mazen et al., 2021 studying a North African cohort, but higher than those reported in other studies [17]. As suggested by Mazen et al., 2021, this rate may be due to a recruitment bias as the research center in Tunisia is a reference centre for cytogenetics. However, it indicates that a considerable proportion of 46,XY DSD cases is due to chromosome anomalies that can be detected during routine karyotyping. aCGH detected further 8 individuals with chromosomal anomalies, associated with 46,XY DSD in 4 patients.

WES is considered the best method for identifying disease causing gene variants in DSD due to the complexity of the phenotypes [18]. Current data indicate that approximately more than half of patients with 46,XY DSD still lack a definite clinical diagnosis at the genetic level after WES [10, 19]. In this North African cohort of DSD, the genetic cause was established in 41.2% (68/165) of the total cohort, with a genetic cause identified in 38.6% of patients following WES. Recent cohort studies, using WES rather than targeted NGS panels have given a diagnosis yield in 46,XY DSD cohorts of 43% and 51% respectively [10, 20]. The lower yield of 38.6% reported here may reflect the proportion of undervirilised men in the cohort, a group that is difficult to reach a definitive clinical diagnosis or establish a genetic etiology [21, 22]. However, similarly to other studies the most common genetic cause was hemizygous variants in the AR [23, 24]. A total of 7 individuals, including two sisters, carried pathogenic variants in the AR. The G744E variant was observed in two unrelated patients, suggesting a possible founder effect for this variant.

A proportion of XY males carrying deletions of 8p23.1 that encompasses the GATA4 gene have hypospadias and bilateral cryptorchidism [25, 26]. Here, a 46,XY female with atypical external genitalia (micropenis, small palpable right testis) carried a 4 Mb microdeletion in the 8p23.1 encompassing the GATA4 gene [27, 28]. Pathogenic variants in GATA4 have been identified in 46,XY DSD with or without cardiac heart defect [27,28,29]. To our knowledge this is the first case with a 8p23 microdeletion in a patient with 46,XY DSD raised as female.

WES revealed several very rare causes of 46,XY DSD including the genes ZNRF3, SOX8 and HHAT. A novel heterozygous missense variant (p.I338M) in ZNRF3 was identified in a 46,XY female with complete gonadal dysgenesis (DSD11). ZNRF3 functions in testis-determination by inhibiting canonical pro-ovary WNT signaling pathway in XY gonads [30]. ZNRF3 does this by targeting Frizzled receptors for degradation by ubiquitination and increased membrane turnover [31]. A total of four rare or novel heterozygous variants (3 missense and one splice region) in ZNRF3 have been reported with both mild and severe 46,XY DSD [30]. All of these variants, including the p.I338M reported here, are located within the C-terminal intracellular domain portion of the protein [31], suggesting a possible genotype/phenotype correlation. SOX8 is an high mobility group (HMG)-box transcription factor, which is co-expressed with SOX9 and NR5A1/SF1 in testis-determination. SOX8 shows functional redundancy with SOX9 and may represses Foxl2 expression [32,33,34]. Heterozygous missense variants in SOX8 are associated with either male or female infertility. Although rearrangements at the SOX8 locus are associated with 46,XY gonadal dysgenesis, only a single pathogenic missense variant, located within the conserved HMG domain (p.E156D), has been demonstrated to cause 46,XY gonadal dysgenesis [35]. Here, a novel heterozygous missense variant p.T226P, located within transactivation (TA) domain, was carried by a 46,XY female with testicular regression syndrome. The p.T226 residue is conserved within the SOXE group of proteins, suggesting a functional role. The mode of inheritance of the ZNRF3 and SOX8 variants mutation is unknown, as the parents were unavailable for study. Hedgehog acyltransferase (HHAT) is an ER-resident multipass membrane protein consisting of 10 transmembrane domains and 2 re-entrant loops [36]. It is a member of the membrane bound-O-acyltransferase (MBOAT) family of enzymes that catalyze the attachment of specific fatty acids to secreted proteins [37]. Hhat−/− mice display severely impaired development of fetal Leydig cells, Sertoli cells and testis cords[16]. In humans, biallelic pathogenic variants in HHAT are very rare and associated with a wide spectrum of neurodevelopmental phenotype including microcephaly, cerebellar vermis hypoplasia, gonadal dysgenesis, seizures and thinning of corpus callosum [16, 38, 39]. Only four families have been described in the literature and the common features are microcephaly and gonadal dysgenesis. Here, we identified a novel homozygous missense variant (p.R312S) in the conserved MBOAT domain-2 of HHAT carried by a 46,XY female with somatic anomalies including hydrocephalus, agenesis of the corpus callosum, skeletal malformations and bilateral anophtalmia.


A combination of cytogenetics and exome sequencing can explain the genetic cause of 46,XY DSD in just over 40% of all cases. Exome sequencing is particularly useful in detecting very rare genetic causes of DSD in genes such as ZNRF3, SOX8 or HHAT that would otherwise have been difficult to determine using other approaches.

Availability of data and materials

Please contact the author for data requests.



Array comparative genomic hybridization


Desoxyribonucleic Acid


Differences/disorders of sex development


High mobility group


Klinefelter syndrome


Whole exome sequencing


  1. Hughes IA. Disorders of sex development : a new definition and classification. Best Pract Res Clin Endocrinol Metab. 2008;22(1):119–34.

    Article  PubMed  Google Scholar 

  2. Ostrer H. Disorders of sex development (DSDs): An update. J Clin Endocrinol Metab. 2014;99(5):1503–9.

    Article  CAS  PubMed  Google Scholar 

  3. Acién P, Acién M. Disorders of sex development: Classification, review, and impact on fertility. J Clin Med. 2020;9:1–33.

    Article  Google Scholar 

  4. Abdullah MA, Katugampola M, Al-Habib S, Al-Jurayyan N, Al-Samarrai Al-Nuaim AA, Patel PJ, et al. Ambiguous genitalia: Medical, socio-cultural and religious factors affecting management in Saudi Arabia. Ann Trop Paediatr. 1991;11(4):343–8.

    Article  CAS  PubMed  Google Scholar 

  5. Mazen I, Hiort O, Bassiouny R, El Gammal M. Differential diagnosis of disorders of sex development in Egypt. Horm Res. 2008;70(2):118–23.

    CAS  PubMed  Google Scholar 

  6. Thyen U, Lanz K, Holterhus PM, Hiort O. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Horm Res. 2006;66(4):195–203.

    CAS  PubMed  Google Scholar 

  7. Sax L. How common is intersex? A response to Anne Fausto-Sterling. J Sex Res. 2002;39(3):174–8.

    Article  PubMed  Google Scholar 

  8. Bashamboo A, McElreavey K. Consanguinity and disorders of sex development. Hum Hered. 2014;77(1–4):108–17.

    Article  PubMed  Google Scholar 

  9. Elzaiat M, McElreavey K, Bashamboo A. Genetics of 46, XY gonadal dysgenesis. Best Pract Res Clin Endocrinol Metab. 2022;36(1):101–633. 

  10. Globa E, Zelinska N, Shcherbak Y, Bignon-Topalovic J, Bashamboo A, McElreavey K. Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings. Front Endocrinol (Lausanne). 2022;13(March):1–14.

    Google Scholar 

  11. Jean McGowan-Jordan RJH and SM. International System for Human Cytogenomic Nomenclature 2020(ISCN). Switzerland: Karger; 2020. 1–503.

  12. Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99(4):877–85. 

  13. Venselaar H, te Beek TAH, Kuipers RKP, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010;11:548.

  14. Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W. Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector, Karl Voelkerding and HLR. Standards and guidelines for the interpretation of sequence variants. Genet Med. 2015;17(5):405–24.

  15. Rjiba K, Ayech H, Kraiem O, Slimani W, Jelloul A, Ben Hadj Hmida I, et al. Disorders of sex development in Wolf-Hirschhorn syndrome: a genotype–phenotype correlation and MSX1 as candidate gene. Mol Cytogenet. 2021;14(1):1–9. 

  16. Callier P, Calvel P, Matevossian A, Makrythanasis P, Bernard P, Kurosaka H, et al. Loss of Function Mutation in the Palmitoyl-Transferase HHAT Leads to Syndromic 46 , XY Disorder of Sex Development by Impeding Hedgehog Protein Palmitoylation and Signaling. PLOS Genet. 2014;10(5):1–12.

  17. Juniarto AZ, van der Zwan YG, Santosa A, Ariani MD, Eggers S, Hersmus R, et al. Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia. Clin Endocrinol (Oxf). 2016;85(2):247–57.

    Article  CAS  PubMed  Google Scholar 

  18. Wisniewski AB, Batista RL, Costa EMF, Finlayson C, Helena M, Sircili P, et al. Management of 46,XY Differences/Disorders of Sex Development (DSD) throughout Life. Endocr Rev. 2019;40(6):1547–72.

  19. Abualsaud D, Hashem M, Alhashem A, Alkuraya FS. Survey of disorders of sex development in a large cohort of patients with diverse Mendelian phenotypes. Am J Med Genet Part A. 2020;1:1–12.

  20. Zidoune H, Ladjouze A, Chellat-rezgoune D, Boukri A, Aman S, Tebibel M, et al. Novel Genomic variants, atypical phenotypes and evidence of a digenic/oligogenic contribution to Disorders of Sex Development in a large North African Cohort. : Front Genet. 2022;13.

  21. I A Hughes 1, C Houk, S F Ahmed, P A Lee LCGECG. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554–63.

  22. Ahmed SF, Alimusina M, Batista RL, Domenice S, Lisboa Gomes N, McGowan R, et al. The Use of Genetics for Reaching a Diagnosis in XY DSD. Sex Dev. 2022;1–18.

  23. Yu B, Liu Z, Gao Y, Wang X, Mao J, Nie M, et al. Prevalence of gene mutations in a Chinese 46, XY disorders of sex development cohort detected by targeted next-generation sequencing. Asian J Androl. 2021;2(October 2019):69–73.

    Google Scholar 

  24. Xue M, Wang X, Li C, Zhao M, He F, Li X. Novel pathogenic mutations in disorders of sex development associated genes cause 46,XY complete gonadal dysgenesis. Gene. 2019;718:1–11.

  25. Wat MJ, Shchelochkov OA, Holder AM, Breman AM, Dagli A, Bacino C, et al. Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet Part A. 2009;149(8):1661–77.

    Article  Google Scholar 

  26. Wagner-Mahler K, Kurzenne JY, Gastaud F, Hoflack M, Panaia Ferrari P, Berard E, et al. Is interstitial 8p23 microdeletion responsible of 46, XY gonadal dysgenesis? One case report from birth to puberty. Mol Genet Genomic Med. 2019;7(3):1–9.

    Article  Google Scholar 

  27. de LaPiscina IM, de Mingo C, Riedl S, Rodriguez A, Pandey AV, Fernández-Cancio M, et al. GATA4 variants in individuals with a 46, XY Disorder of Sex Development (DSD) may or may not be associated with cardiac defects depending on second hits in other DSD genes. Front Endocrinol (Lausanne). 2018;9(APR):1–10.

    Google Scholar 

  28. Bashamboo A, McElreavey K. Mechanism of Sex Determination in Humans: Insights from Disorders of Sex Development. Sex Dev. 2016;10(5–6):313–25.

    Article  CAS  PubMed  Google Scholar 

  29. Lourenço D, Brauner R, Rybczyńska M, Nihoul-Fékété C, McElreavey K, Bashamboo A. Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci U S A. 2011;108(4):1597–602.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Harris A, Siggers P, Corrochano S, Warr N, Sagar D, Grimes DT, et al. ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling. Proc Natl Acad Sci U S A. 2018;115(21):5474–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hao HX, Xie Y, Zhang Y, Zhang O, Oster E, Avello M, et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature. 2012;485(7397):195–202.

    Article  CAS  PubMed  Google Scholar 

  32. Chassot AA, Gillot I, Chaboissier MC. R-spondin1, WNT4, and the ctnnb1 signaling pathway: Strict control over ovarian differentiation. Reproduction. 2014;148(6):R97-110.

    Article  PubMed  Google Scholar 

  33. Gonen N, Quinn A, O’Neill HC, Koopman P, Lovell-Badge R. Normal Levels of Sox9 Expression in the Developing Mouse Testis Depend on the TES/TESCO Enhancer, but This Does Not Act Alone. PLoS Genet. 2017;13(1):1–17.

    Article  Google Scholar 

  34. Nicol B, Yao HHC. Gonadal identity in the absence of pro-testis factor SOX9 and pro-ovary factor beta-catenin in mice. Biol Reprod. 2015;93(2):1–12.

    Article  CAS  Google Scholar 

  35. Portnoi MF, Dumargne MC, Rojo S, Witchel SF, Duncan AJ, Eozenou C, et al. Mutations involving the SRY-related gene SOX8 are associated with a spectrum of human reproductive anomalies. Hum Mol Genet. 2018;27(7):1228–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Matevossian A, Resh MD. Membrane topology of hedgehog acyltransferase. J Biol Chem . 2015;290(4):2235–43. 

  37. Hardy RY, Resh MD. Identification of N-terminal residues of sonic hedgehog important for palmitoylation by Hedgehog acyltransferase. J Biol Chem. 2012;287(51):42881–9. 

  38. Mazen I, Mekkawy M, Kamel A, Essawi M, Hassan H, Abdel-Hamid M, et al. Advances in genomic diagnosis of a large cohort of Egyptian patients with disorders of sex development. Am J Med Genet Part A. 2021;185(6):1666–77.

    Article  CAS  PubMed  Google Scholar 

  39. Abdel-Salam GMH, Mazen I, Eid M, Ewida N, Shaheen R, Alkuraya FS. Biallelic novel missense HHAT variant causes syndromic microcephaly and cerebellar-vermis hypoplasia. Am J Med Genet Part A. 2019;179(6):1053–7.

    Article  CAS  PubMed  Google Scholar 

Download references


The authors would like to express their sincere gratitude to all patients and their parents for their participation in this work. We are grateful to the associated clinicians for providing detailed clinical information and we also thank Mhadheb Msaoura for English editing.


This work is funded in part by a research grant from the European Society of Pediatric Endocrinology, a scholarship from the Tunisian government, and by the Agence Nationale de la Recherche (ANR), ANR-10-LABX-73 REVIVE, ANR-17-CE14-0038–01, ANR-19-CE14-0022, ANR-20-CE14-0007 and ANR-19-CE14-0012.

Author information

Authors and Affiliations



K.R carried out the cytogenetic and molecular genetic studies, analyzed the datasets, and performed protein sequence alignment. I.H, W.S, H.B.K and J.B.T participated in some experiments. G.S, A.J, Y.H, S.D, A.S, M.K, H.A, M.G, H.K, M.B, S.C, M.K and A.S provided detailed clinical data and critically evaluated the manuscript. S.M.Z, A.B and K.M. designed the study, drafted the final manuscript, and analyzed datasets.

Corresponding author

Correspondence to Kenneth McElreavey.

Ethics declarations

Ethics approval and consent to participate

The local Ethics Board of the University Teaching Hospital Farhat Hached approved the present study (IRB00008931) and written consents were taken from the parents for data publication.

Consent for publication

Consent for publication of all patients has been obtained.

Competing interests

The authors declare that there are no competing financial interests in relation to the work described.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rjiba, K., Mougou-Zerelli, S., Hamida, I.h. et al. Additional evidence for the role of chromosomal imbalances and SOX8, ZNRF3 and HHAT gene variants in early human testis development. Reprod Biol Endocrinol 21, 2 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: